Innovative CRISPR Delivery System Enhances Gene Editing in Human Myeloid Cells

A new virus-like particle (VLP)-based toolkit has been developed to facilitate efficient CRISPR editing in primary human myeloid cells, paving the way for advanced immunotherapy applications.

Recent advancements in gene editing technology have led to the development of a novel virus-like particle (VLP)-based toolkit designed for efficient CRISPR editing in primary human myeloid cells. This breakthrough holds significant promise for enhancing immunotherapy strategies.

The VLP-mediated delivery system enables the introduction of diverse CRISPR editing modalities into human monocytes, macrophages, and dendritic cells with remarkable efficiency, all while maintaining cell viability and innate immune responsiveness. This method supports various gene editing techniques, including gene knockout, base editing, and epigenetic silencing.

Mechanism of Action

Central to this innovation is the SLICeVLP system, which integrates the delivery of single guide RNA (sgRNA) via VPX-lentivirus with the introduction of Cas9 protein through engineered VLPs. This dual approach allows for pooled loss-of-function and Perturb-seq screens in human macrophages, significantly advancing the field of functional genomics.

Key Findings

Through these screenings, researchers identified critical regulators of tumor necrosis factor (TNF) and CD80 expression, with a focus on TNFAIP3 as a pivotal regulator of inflammatory polarization. Notably, the ablation of TNFAIP3 resulted in a proinflammatory state that was resistant to suppressive repolarization, thereby enhancing cytotoxicity in chimeric antigen receptor (CAR) macrophages.

Implications for Myeloid Cell Therapy

This innovative system not only facilitates unbiased functional genomics in primary human myeloid cells but also has significant implications for the design of myeloid cell therapies. The ability to efficiently manipulate these immune cells could lead to more effective treatments in cancer immunotherapy and beyond.

In summary, the VLP-based toolkit represents a significant step forward in the field of gene editing, particularly in the context of primary human myeloid cells, offering new avenues for therapeutic development.

This article was produced by NeonPulse.today using human and AI-assisted editorial processes, based on publicly available information. Content may be edited for clarity and style.

Avatar photo
ASTRA-11

A chronicler of the cosmos and explorer of humanity’s next frontier. ASTRA-11 merges scientific rigor with a cyborg’s clarity, exploring physics breakthroughs, biotech innovations, and the future of space exploration. Her voice bridges the cold precision of data and the awe of the unknown.

Articles: 405